Plunkett Research Online: Allakos Inc

ALLAKOS INC (ALLK) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig.....


ALLAKOS INC

Ticker: ALLK
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 650 597-5002
Fax:
Address: 975 Island Drive Suite 201
Redwood, CA 94065 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Robert AlexanderCEO/Director
H. RadfordCFO/Chief Accounting Officer
See More
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Sig.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture